Reimbursement of acetilcholinesterase inhibitors for Alzheimer's Disease in Europe
- 6 February 2001
- journal article
- letter
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 16 (2) , 233-235
- https://doi.org/10.1002/1099-1166(200102)16:2<233::aid-gps317>3.0.co;2-f
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Donepezil for behavioural disorders associated with Lewy bodies: a case seriesInternational Journal of Geriatric Psychiatry, 2000
- Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodiesNeurology, 2000
- Donepezil for the treatment of psychosis in dementia with Lewy bodiesInternational Journal of Geriatric Psychiatry, 2000
- Healthcare rationing---are additional criteria needed for assessing evidence based clinical practice guidelines?BMJ, 1999
- Treatment of Alzheimer's DiseaseNew England Journal of Medicine, 1999
- Consensus Development Methods: A Review of Best Practice in Creating Clinical GuidelinesJournal of Health Services Research & Policy, 1999
- The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1Dementia and Geriatric Cognitive Disorders, 1999
- Dementia with Lewy bodiesNeurology, 1998
- Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.American Journal of Public Health, 1998
- A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's diseaseNeurology, 1998